BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26186456)

  • 1. Acceptability and Feasibility of Delivering Pentavalent Vaccines in a Compact, Prefilled, Autodisable Device in Vietnam and Senegal.
    Guillermet E; Dicko HM; Mai le TP; N'Diaye M; Hane F; Ba SO; Gomis K; Tho NT; Lien NT; Than PD; Dinh TV; Jaillard P; Gessner BD; Colombini A
    PLoS One; 2015; 10(7):e0132292. PubMed ID: 26186456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device.
    Sutanto A; Suarnawa IM; Nelson CM; Stewart T; Soewarso TI
    Bull World Health Organ; 1999; 77(2):119-26. PubMed ID: 10083709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
    Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI
    Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and Peru.
    Nogier C; Hanlon P; Wiedenmayer K; Maire N
    Drugs Real World Outcomes; 2015 Mar; 2(1):43-52. PubMed ID: 27747612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Care Worker Preferences and Perspectives on Doses per Container for 2 Lyophilized Vaccines in Senegal, Vietnam, and Zambia.
    Kanagat N; Krudwig K; Wilkins KA; Kaweme S; Phiri G; Mwansa FD; Mvundura M; Robertson J; Kristensen D; Gueye A; Dao SD; Thai PQ; Nguyen HT; Tran TC
    Glob Health Sci Pract; 2020 Dec; 8(4):680-688. PubMed ID: 33361235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case study of an influenza vaccination program for health care workers in Vietnam.
    Ha NT; Nguyen TTM; Nguyen TX; Tran PD; Nguyen HM; Ha VT; Lafond KE; Seward JF; McFarland JW; Chu SY
    BMC Health Serv Res; 2020 Aug; 20(1):785. PubMed ID: 32831071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.
    Drain PK; Nelson CM; Lloyd JS
    Bull World Health Organ; 2003; 81(10):726-31. PubMed ID: 14758432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: a modelling and cost-optimisation study.
    Seaman CP; Morgan C; Howell J; Xiao Y; Spearman CW; Sonderup M; Lesi O; Andersson MI; Hellard ME; Scott N
    Lancet Glob Health; 2020 Jul; 8(7):e931-e941. PubMed ID: 32562649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats.
    Sedita J; Perrella S; Morio M; Berbari M; Hsu JS; Saxon E; Jarrahian C; Rein-Weston A; Zehrung D
    Vaccine; 2018 Mar; 36(12):1700-1709. PubMed ID: 29449099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reuse prevention syringes for reconstitution of lyophilized vaccines: Operational study and UNICEF plans for expanding introduction.
    Fleming JA; Hoekstra EJ; Moniaga V; Widjaya A; Soepardi J; Supartha N; Salovaara A; Khamassi S; Nelson C
    Int J Occup Environ Health; 2009; 15(1):9-13. PubMed ID: 19267121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of complete immunization among senegalese children aged 12-23 months: evidence from the demographic and health survey.
    Mbengue MAS; Sarr M; Faye A; Badiane O; Camara FBN; Mboup S; Dieye TN
    BMC Public Health; 2017 Jul; 17(1):630. PubMed ID: 28683781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countries.
    Guillermet E; Alfa DA; Phuong Mai LT; Subedi M; Demolis R; Giersing B; Jaillard P
    Vaccine; 2019 Jul; 37(32):4435-4443. PubMed ID: 30890383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan: protocol for a randomized controlled trial.
    Siddiqi DA; Munir M; Shah MT; Khan AJ; Chandir S
    BMC Public Health; 2019 Oct; 19(1):1421. PubMed ID: 31666039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination coverage and immunization timeliness among children aged 12-23 months in Senegal: a Kaplan-Meier and Cox regression analysis approach.
    Mbengue MAS; Mboup A; Ly ID; Faye A; Camara FBN; Thiam M; Ndiaye BP; Dieye TN; Mboup S
    Pan Afr Med J; 2017; 27(Suppl 3):8. PubMed ID: 29296143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
    Jarrahian C; Rein-Weston A; Saxon G; Creelman B; Kachmarik G; Anand A; Zehrung D
    Vaccine; 2017 Mar; 35(14):1789-1796. PubMed ID: 28189403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost of tetanus toxoid injection using a jet-injector (Imule) in collective immunization in Senegal: comparison with injection using a syringe and resterilizable needle].
    Schlumberger M; Châtelet IP; Lafarge H; Genêt A; Gaye AB; Monnereau A; Sanou C; Diawara L; Gueye Y; Lang J
    Sante; 1999; 9(5):319-26. PubMed ID: 10657777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
    Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
    Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
    Mvundura M; Frivold C; Janik Osborne A; Soni P; Robertson J; Kumar S; Anena J; Gueye A; Menozzi-Arnaud M; Giersing B; Kahn AL; Scarna T; Kristensen D
    Vaccine; 2021 Dec; 39(49):7195-7207. PubMed ID: 34412922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis.
    Dutta T; Agley J; Meyerson BE; Barnes PA; Sherwood-Laughlin C; Nicholson-Crotty J
    PLoS One; 2021; 16(6):e0253318. PubMed ID: 34170920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.